Delivery Order SPE2DX22D0010-SPE2D825FDB17
Award Date
1/28/25
Potential Completion Date
1/29/25
Potential Value
$4.8K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,777.05 firm fixed-price delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 3, 2025. This appears to be a component of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a prescription medication, with a ceiling value of $3,276.66 and a completion date of January 22, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,005.90 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension, a prescription medication. The contract has an ultimate completion date of January 29, 2025 and was awarded on January 28, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,398.84, is for the supply of Quillivant XR 25 mg/5 ml suspension, a medication used in the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, 120 ml, with a potential value of $1,270.30 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Quillivant XR 25 mg/5 ml suspension (180 ml). The contract has a ceiling value of $1,314.20 and a completion date of January 23, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,314.20, is a Firm Fixed Price Delivery Order for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Quillivant XR 25 mg/5 ml suspension, 60 ml, to the U.S. government. The $2,592.57 firm fixed-price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), and has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Quillivant XR 25 mg/5 ml suspension, a medication, and has a ceiling value of $1,577.04. The contract is a firm fixed-price Delivery Order with a completion date of January 22, 2025. The contract is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,128.16 firm fixed-price delivery order is for the supply of Quillivant XR 25 mg/5 ml suspension in 150 ml bottles, with a completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...